3651 results for «301»
3651 results
The uncrossable lesion
16 May 2024 – From EuroPCR 2024
This session delves into the challenges of dealing with uncrossable and heavily calcified coronary lesions. It features a variety of cases showcasing the use of specialized techniques and tools, such as the excimer laser, to overcome these obstacles. The session emphasizes the importance of troubleshooting, utilizing...
TAV-in-TAV in complex situations
16 May 2024 – From EuroPCR 2024
This session comprises selected EuroPCR 2024 Clinical Case submissions focused on TAVI-in-TAVI procedures in complex situations. It covers various case presentations and discussions, including re-do TAVI with the risk of acute coronary obstruction, expanding possibilities in TAVR-in-TAVR with the mid-leaflet implantation technique, transcatheter valve-in-valve in self-expanding...
When mitral valve intervention goes wrong
16 May 2024 – From EuroPCR 2024
This session examines various complications that can arise during mitral valve interventions, such as iatrogenic aortic root perforation, unexpected leakage, and other challenging scenarios. The presenters share their experiences in managing these complications and the strategies they employed to address them. The session emphasizes the importance...
Which techniques to improve results of PCI in calcified lesions
16 May 2024 – From EuroPCR 2024
This session comprises selected EuroPCR 2024 Clinical Case submissions focused on techniques to improve PCI outcomes in calcified lesions. It covers various case presentations and discussions, including the use of imaging to guide therapy for calcified noduli, planning strategies for tortuous and calcified lesions, managing balloon-undilatable...
Intracoronary imaging: diagnosis
16 May 2024 – From EuroPCR 2024
This session highlights the pivotal role of intracoronary imaging techniques, such as OCT and IVUS, in the diagnosis of various cardiovascular conditions. The presenters share case studies that demonstrate how these imaging modalities can help differentiate acute coronary syndrome from other conditions, identify the underlying causes...
Unusual causes of acute coronary syndrome in the cathlab
16 May 2024 – From EuroPCR 2024
This session comprises selected EuroPCR 2024 Clinical Case submissions focused on unusual causes of acute coronary syndrome encountered in the catheterization laboratory. It covers various case presentations and discussions, including left main disease and STEMI in a young woman, STEMI secondary to antiphospholip syndrome, and Kawasaki...
Stent loss and coronary perforation: how to deal with
16 May 2024 – From EuroPCR 2024
This session explores the management of challenging complications during percutaneous coronary interventions, such as stent loss and coronary perforation. The presenters share case studies that demonstrate various techniques and strategies used to address these complications, including the use of CTO wires for distal wire perforation, managing...
Left main: presentation and diagnosis
16 May 2024 – From EuroPCR 2024
This session comprises selected EuroPCR 2024 Clinical Case submissions focused on the presentation and diagnosis of left main coronary artery disease. It covers various case presentations and discussions, including isolated aortitis with critical coronary ostial stenosis due to Takayasu arteritis, acute left main occlusion, and critically...
The PASCAL IID Registry: A prospective registry for transcatheter edge-to-edge repair in prohibitive risk patients with degenerative mitral regurgitation and complex mitral valve anatomy
17 Sep 2022
Alex Sticchi provides his take on the PASCAL IID Registry and an initial comparison with the CLASP IID. The trial was presented by Jörg Hausleiter during TCT Congress 2022.
Author
Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial
07 Apr 2024
REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.
Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...
Author
Author
SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk
07 Nov 2021
Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...
Author
Author
